课题基金 / 基金详情

OSTEOGENIC FACTOR FROM DENTIN MATRIX

OSTEOGENIC FACTOR FROM DENTIN MATRIX
牙本质基质的成骨因子
批准号:
3222294
负责人:
ARTHUR VEIS
金额:
$14.82万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-01 至 1992-08-31

项目摘要

项目成果

ARTHUR VEIS的其他基金

相似基金

相关文献

中文摘要
翻译
矿化组织的细胞外基质中含有一种蛋白质
英文摘要
Mineralized tissues contain in their extracellular matrix a protein factor which has the capacity to induce chondrogenesis and osteogenesis in soft tissues that normally do not form cartilage or bone. Urist has called this factor BMP, the bone morphogenetic protein. Efforts to characterize this protein from bone have not been successful because of the small amount and highly interactive nature of BMP, and the complex composition of the bone. Moreover, the assay systems, involving in vivo implantation, have required large amounts of protein. We have approached this problem from two fresh perspectives: 1) an in vitro cell culture assay has been developed; 2) use has been made of the fact that dentin matrix has a higher BMP activity than bone matrix. In our initial studies we have demonstrated the presence of a factor in the rat dentin matrix which is chondrogenic in vitro and osteogenic in vivo, extracted and fractionated the noncollagenous proteins, located the fraction with fractionated the noncollagenous proteins, located the fraction with fractionated the noncollagenous proteins, located the fraction with fractionated the noncollagenous proteins, located the fraction with in vitro chondrogenic activity, and shown that nonmyogenic nionatal rat muscle fibroblasts have receptors for its uptake. We now propose to: 1) purify the CIA to homogeneity and obtain its amino aid sequence; 2) determine its in vivo activity; 3) prepare immunologic and nucleotide probes for its identification; 4) quantitate the receptor binding site and determine the nature of the receptor and the uptake process; 5) examine the role of growth factors and other regulatory agents on its activity in vitro; and 6) explore the use of CIA in vivo in bone defect repair. We believe that these studies can be of immense importance in bringing closer the application of chondrogenic and osteogenic agents to the repair of bone defects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signaling activities of amelogenin gene splice products.
Signaling activities of amelogenin gene splice products
Signaling activities of amelogenin gene splice products.
Signaling activities of amelogenin gene splice products.
海外基金